Disc Medicine (IRON) Other Non-Current Assets (2020 - 2026)
Disc Medicine (IRON) posted quarterly Other Non-Current Assets of $496000.0 for Q2 2026, down 40.95% year-over-year from $840000.0 in Q2 2025, and down 31.21% quarter-over-quarter from $721000.0 in Q1 2026.
Powered by 
Analysis
Disc Medicine (IRON) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has reported Other Non-Current Assets for 7 consecutive years, with $496000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Non-Current Assets fell 40.95% year-over-year to $496000.0; the TTM figure through Jun 2026 stood at $496000.0 (down 40.95% YoY), while the FY2025 annual figure was $726000.0, down 13.37% from the prior year.
- Other Non-Current Assets eased to $496000.0 in Q2 2026 per IRON's latest filing, from $721000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.4 million in Q3 2022 and bottomed at $116000.0 in Q4 2022.
- Historically, Other Non-Current Assets has averaged $471833.3 across 5 years, with a median of $236000.0 in 2024.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 323.22% — and 2023, when it sank 91.51%.
- Disc Medicine's Other Non-Current Assets stood at $116000.0 in 2022, then soared by 101.72% to $234000.0 in 2023, then jumped by 258.12% to $838000.0 in 2024, then declined by 13.37% to $726000.0 in 2025, then plunged by 31.68% to $496000.0 in 2026.
- Business Quant data shows IRON's Other Non-Current Assets at $496000.0 in Q2 2026, $721000.0 in Q1 2026, and $726000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 618.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 42.45 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 109.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 65.13 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 62.96 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Disc Medicine | 3.06 Bn | 3.06 Bn | - | 496,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 496,000.00 |
| Mar 31, 2026 | 721,000.00 |
| Dec 31, 2025 | 726,000.00 |
| Sep 30, 2025 | 840,000.00 |
| Jun 30, 2025 | 840,000.00 |
| Mar 31, 2025 | 839,000.00 |
| Dec 31, 2024 | 838,000.00 |
| Sep 30, 2024 | 236,000.00 |
| Jun 30, 2024 | 236,000.00 |
| Mar 31, 2024 | 235,000.00 |
| Dec 31, 2023 | 234,000.00 |
| Sep 30, 2023 | 116,000.00 |
| Jun 30, 2023 | 116,000.00 |
| Mar 31, 2023 | 116,000.00 |
| Dec 31, 2022 | 116,000.00 |
| Sep 30, 2022 | 1.37 Mn |
| Jun 30, 2022 | 204,000.00 |
| Mar 31, 2022 | 217,000.00 |
| Dec 31, 2021 | 180,000.00 |
| Sep 30, 2021 | 323,000.00 |